Zuvest
← All research
Latest research ·

NVDA NVIDIA Corporation

Technology · Semiconductors
$152.10
-2.16% on the day · price at time of report
Cautious
CautiousNeutralConstructive

Verdict by horizon

Long-term investing
Wait for a better price

The market fears the end of the AI capex boom, but NVIDIA's ROIC of 114%, net cash and FCF of $97B suggest a durable franchise. Value is likely between the DCF ($92) and the analyst targets ($254). At $152, upside to my base of about $105 is negative, so

Swing trading
No valid setup

For a long: an undercut of 148.8 that closes back above it with volume, a reclaim of EMA10 168.68 / EMA21 184.29 with RSI14 above 40, and a contracting base. For a short: a daily close below 148.8 with no oversold-bounce reversal.

Day trading
Bias: short

Price 152.10 is below VWAP 153.06, RVOL 3.13 (>=2, in play) and has used 99% of its ADR (8.98), so remaining range is limited. The open gapped up 2.4% to 159.19 and sold off to LOD 150.85. Day type is mixed with 4 VWAP crosses, so avoid trend-day assumption

Options
Bear put debit spread 152/150, Dec 18, 1 contract

FAIR: IV/HV20 is 1.04 (ATM IV 53.6% at 30 DTE vs HV20 51.6% and HV60 44.0%). The term structure is inverted (59.8% at 5 DTE, 53.6% at 30 DTE, 50.7% at 58 DTE). 25-delta put skew is +7.0 to +7.4 pts, so puts are bid. IV rank is unknown (it needs a year of IV hi

Views by discipline

▤ Fundamentals & valuationneutral · 55
⌕ Accounting quality & eventsneutral · 55
◍ Macro, policy & creditbearish · 68
⟋ Technical analysisbearish · 85
⇄ Positioning & sentimentbearish · 60

Valuation snapshot

Fair value (bear / base / bull)$54.00 / $105.00 / $165.00
Street mean target$253.67
P/E fwd · FCF yield · ROIC9.2 · 2.64% · 113.9%

NVIDIA Corporation operates as a data center scale AI infrastructure company in the United States, Taiwan, China, Hong Kong, Europe, and internationally. It operates through Compute & Networking, and Graphics segments. The Compute & Networking segment provides data center accelerated computing and networking platforms and artificial intelligence solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment offers GeForce

Charts

Price, indicators & swing plan

Intraday & day-trade plan

Research views

Valuation

Relative strength

Fundamentals

Options

Market backdrop

Research memo

Bottom line

  • Long-term investing: WAIT. Do not buy at about $152. NVIDIA is a superb business, with ROIC of 113.9% against a WACC of 13.03%. But the fundamental analyst's expected value is about $107, and the suggested buy zone is $100–120. At today's price there is no margin of safety.
  • Swing trading: NO TRADE today. There is no valid long setup. The chart is in Stage 4 and passes only 2 of 8 Trend Template checks. A breakdown short becomes a watchlist idea only if the stock closes a day below $148.8, and even then the risk review requires a separate review first.
  • Day trading: small, conditional, one idea at a time. The VWAP-rejection short and the oversold-bounce long were both approved only at reduced (half) size. The support-breakdown short was rejected because its reward-to-risk was only 1.0. It is currently around 12:23 ET, inside the 11:30–14:00 midday chop window, which the plan says to avoid.
  • Options: one defined-risk bearish idea was approved. It is a Dec 18 152/150 bear put debit spread. Maximum loss is $95 and maximum profit is $105. That payoff is thin, about 1.1 times the risk.
  • The single most important risk is a violent oversold bounce. RSI2 is 2.6, the price is only 2.2% above its 52-week low, and there is heavy speculative call buying. CEO-succession headlines can also gap the stock in either direction. A short-side idea can be right on the trend and still get stopped out by one sharp rally.

Long-term investment view

Stance: neutral, wait for a better price or better evidence. The fundamental analyst rates the business quality grade A but sets the stance at neutral, with 55% confidence.

What is great about the business: - Operating margin is 60.4%. - FCF (free cash flow) is $96.7B, with 81% conversion. That means most reported profit turns into cash. - Net cash is $51.5B. - Interest coverage is 547x. - Stock-based pay is only 3.0% of revenue, and the diluted share count is falling. - Distress risk is effectively nil (Altman Z of 49.2).

Why the price is still not attractive: - The valuation tools conflict. Cheap multiples (forward P/E 9.2, PEG 0.19) say "bargain." The mechanical DCF gives a probability-weighted value of about $91. The reverse DCF says today's price already assumes about 40% starting FCF growth, against a 25% base case. - A reverse DCF works backward from the current price to find the growth the market is already assuming. - When valuation tools disagree this much says to assume the market may know something you don't. - The DCF may be too harsh. It uses a 13% WACC built on a beta of 1.6. The analyst adjusted the values up to bear $54, base $105 and bull $165. Even the adjusted base case is below $152. - Growth is slowing from a very high level. Revenue growth went 125.9% → 114.2% → 65.5%. Gross margin slipped from 75.0% to 71.1%. - Forensic verdict: WATCH, not red flag. - The Beneish M-Score is -1.27, above the -1.78 threshold, but it is mostly driven by fast growth. - The cash-flow accruals ratio is 59.4%. - Inventory grew 112% against revenue growth of 65%. If demand cools, write-downs could follow. - Data problems lower confidence. The trailing P/E (19.2) and forward P/E (9.2) do not reconcile. The earnings release on 2026-11-17 is out, but its figures and guidance are unknown in our data.

What would prove the wait-stance wrong (falsification): - Turn bullish if: the actual results and guidance show growth well above 40% with gross margin stabilizing at about 70% or higher. - Turn bearish if: hyperscalers cut capex, gross margin falls below about 65%, or revenue growth drops under 20%. - Consider buying if: the price reaches the $100–120 zone, which would offer a real margin of safety.

Swing trading view

No trade. Every swing-relevant lens points down: - Technical (85% confidence): - Price is 25–28% below the key moving averages (SMA50 $210.33, SMA200 $203.46). - ADX is 47 with -DI at 44.6, which signals a strong downtrend. - Pullbacks are getting deeper (12.2% → 14.4% → 47.8%). That is the opposite of a constructive base. - Flow: - 9 distribution days against 2 accumulation days. - Insider activity is sales only: $1,370.53M in 180 days, with no buys. - Macro (HEADWIND): - SPY is only 0.01% above its 200-day average. - VIX is 25.48 and in backwardation, meaning near-term fear is priced above longer-term fear. - The 10-year yield is about 5.06%. - The macro analyst recommends reduced position sizes.

Conditional idea, not a recommendation. A swing short could be considered only after a daily close below $148.8, the 52-week low and the Donchian 20/55-day low. Two cautions apply: 1. The plan's stop is about 8 points away, so only a tiny position fits a $50 risk budget. 2. The plan labels the entry a "buy-stop," but a short would actually use a sell-stop. That kind of error is exactly why the risk review requires a fresh review before acting.

Long swing: wait for all of the following before considering one: - An undercut of $148.8 that closes back above it on strong volume (a "spring"). - A reclaim of the 10- and 21-day EMAs ($168.68 / $184.29). - RSI14 back above 40. - Contracting price ranges that start to form a base.

Day trading view (today / next session)

Context: - NVDA is "in play": relative volume is 3.13x normal. - It trades below VWAP at $153.06. VWAP is the volume-weighted average price, a common intraday reference line. - The day is choppy, with 4 VWAP crosses. - 99% of the average daily range is already used, so little room may be left today. - Regime favors the short side, but RSI2 of 2.6 says bounces can be sharp.

Risk-checked plans (the risk review's verdicts are final):

  1. VWAP rejection short (approved at reduced size).
  2. Act only on a clear failed rally into VWAP: a wick or red 5-minute candle while price stays below about $155.46.
  3. Entry about $152.9, stop $154.0, targets $150.85 then $148.8. Reward-to-risk is 1.86.
  4. Best windows are 14:00–15:30 ET today, or the next session.
  5. Note: the $1.10 stop is only about 0.17x ATR, so normal noise can trigger it.

  6. Oversold-bounce reclaim long (approved at reduced size, counter-trend).

  7. Act only if price undercuts $148.8, reclaims it, and then closes a 5-minute bar above VWAP on volume, while SPY is not weak.
  8. Entry about $153.3, stop $151.9, targets $155.46 / $158.19.
  9. Reward-to-risk is 1.54, barely above the 1.5 minimum, so any slippage erases the edge.

  10. LOD/support breakdown short: REJECTED. Reward-to-risk is 1.0, below the 1.5 minimum. Shorting directly into the 52-week low also invites a failed-breakdown reversal. Do not take it.

Account rules: - One idea at a time. Never flip from the short to the counter-trend long in the same stretch of chop. - 1R (one unit of planned risk) is $50. Stop for the day at a $200 loss or 3 losing trades. - Be flat by the close. - Check the PDT rule if this is a US margin account under $25k. The pattern-day-trader rule may limit you to 3 day trades in 5 business days.

Options view

Approved: Dec 18 bear put debit spread, buying the 152 put and selling the 150 put.

Item Value
Net debit (max loss) $95
Max profit $105
Breakeven $151.05
Days to expiration 30

Why this structure: - IV (implied volatility, the volatility priced into options) is about fair: IV/HV20 is 1.04. Fair IV suits a defined-risk debit spread. - The earnings volatility "crush" has likely already happened, since results came out on Nov 17. - Other structures either break the $100 options-risk cap (long puts cost about $1,908–$2,352 per contract) or fight the trend (put credit spreads).

The honest drawback: breakeven is only about 0.7% below spot, and the profit zone is narrow. A bounce toward $158.99–$168.68 would lose most or all of the debit.

Management: - Enter as a single combo limit order at the mid. - Take profit at 50–75% of the maximum. - Exit on a close above $158.99 or on a failed breakdown at $148.8. - Review around 21 days to expiration (about Nov 27). Close by roughly Dec 8–11. - No adds and no rolls.

Where the analysts disagree

  • Cheap or expensive? Forward P/E of 9.2 and PEG of 0.19 say cheap. The DCF (about $91 mechanical, $105 adjusted base) and a 2.64% FCF yield say expensive. Wall Street's mean target is $253.67, which is +67%. My weighting: the DCF and FCF evidence is more trustworthy here. The forward P/E conflicts with the trailing P/E, and low P/Es at peak earnings are a classic semiconductor value trap. Fundamentals win on the investing horizon, and they currently say "wait."
  • Trend or bounce? Technical, flow and macro analysts all lean bearish, with confidence of 85, 60 and 68. Yet every analyst warns about an oversold squeeze. For swing and day horizons, the trend gets priority, but sizes stay small and no new shorts are taken into the $148.8 low itself.
  • Call buying. Unusual volume in the Dec $205 calls (45,969 traded vs 16,959 open interest) could be bullish speculation. The flow analyst notes that volume alone does not reveal direction or who is on the other side. I treat it as a squeeze risk, not as a signal to buy.
  • Leadership news. The flow analyst reports CEO-succession headlines. The forensic analyst notes an 8-K 5.02 officer/director change on Nov 12, with details unknown. I treat this as unverified event risk in both directions, not as a thesis.

What to watch next (catalysts, levels, data)

Earnings details: the actual Q3 FY27 results and guidance (currently unknown). Focus on: - Gross margin versus the 70% line - Revenue growth versus 40% - Inventory and purchase commitments in the 10-Q footnotes

Levels:

Role Price Meaning
Support $148.8 52-week low
Support $146.8 Next support
Support $143.27 Next support
Resistance $158.99 / $162.52 Pivot levels
Resistance $168.68 EMA10
Resistance $184.29 EMA21
  • A daily close below $148.8 brings the swing-short review into play.
  • An undercut and reclaim of $148.8 is the first bullish clue.

Macro triggers: - SPY closing below its 200-day average. - VIX above 30, or backwardation widening. - The 10-year yield sustained above about 5.2%. - The high-yield spread rising above about 4 points (from 3.43).

Filings: - Who left under the 8-K 5.02. A CFO exit would matter more. - Form 4 details, especially whether insider sales were 10b5-1 plan sales. - Analyst target revisions after earnings.

Risk-checked trade plans

Trade plans are illustrative and were risk-checked against a reference $10,000 model portfolio (0.5% risk per trade); any share counts refer to that model portfolio.

dayVWAP rejection shortshortreduced size
Entry152.90
Stop154.00
Targets150.85, 148.80
Reward : risk1.86

Risk review: Passes the checks (R:R 1.86), but the 16 shares are capped by the 25% position rule (position $2,446, 24.5% of the account), so the stop risk is only $17.60. The size is limited by the cap, not by risk. The position is large relative to a $10k account in a stock with a 6.34% ATR and 10 gaps over 3% in a year. A 1.10 stop is only about 0.17x ATR, so noise or slippage can stop it out easily. With 4 VWAP crosses (a choppy day) and RSI2 at 2.6, a squeeze toward VWAP or PDC is likely. Take it only on a confirmed rejection candle, at half the Python size (8 shares), as a day trade closed by the close. Check PDT first: an account under $25k with a margin account is limited to 3 day trades in 5 days.

dayLOD / support breakdown shortshortrejected
Entry150.20
Stop151.60
Targets148.80, 146.80
Reward : risk1.00

Risk review: Hard violation: reward:risk to the first target is 1.00, below the 1.5 day-trade minimum (valid=false). Shorting a break into the 52-week low also risks a failed-breakdown reversal (spring), with the stock already oversold.

dayOversold bounce reclaim (counter-trend, half size)longreduced size
Entry153.30
Stop151.90
Targets155.46, 158.19
Reward : risk1.54

Risk review: Passes the checks (R:R 1.54, barely above the 1.5 minimum), but it is a counter-trend long in a Stage 4 downtrend with a HEADWIND macro regime and VIX in backwardation. The plan's own label says half size, so allow 8 shares at most. Take it only if the 148.8 undercut-and-reclaim happens and SPY is not weak. The edge is thin, so any slippage pushes R:R below 1.5. It counts toward the same PDT and daily-loss budget as day_1.

optionsBear put debit spread 152/150, Dec 18, 1 contractapproved
Legsbuy put 152.00 · sell put 150.00
Expiry2026-12-18
Max loss / contract$95

Risk review: Defined risk: 1 contract with a max loss of $95, within the $100 options budget (1% of the account) and valid=true. Open interest and spreads are acceptable, and it is not a day trade, so PDT does not apply. The payoff is poor: max profit is $105 (about 1.1R) with breakeven at 151.05, only about 0.7% below spot, so a bounce loses most or all of the debit. Keep 1 contract with no adds or rolls, enter as a combo limit at the mid, and exit on a close above 158.99 or a failed breakdown. Never hold into a new event such as CEO-succession news. Count the $95 against the daily and total heat budget.

Analysis by discipline

▤Fundamentals & valuation neutral · 55

NVIDIA is an exceptional business (ROIC 113.9%, operating margin 60.4%, net cash of $51.5B) whose stock has fallen about 30% in a month. The mechanical DCF (probability-weighted $91 vs price $151.57) says the price needs about 40% starting FCF growth. The multiples (forward P/E 9.2, PEG 0.19) say it is cheap, and these two views conflict. The data look inconsistent (trailing P/E 19.2 vs forward 9.2, a 'next earnings' date already passed with no results). I would hold or wait for a better price rather than chase, and I would accumulate only below the base-case value.

Key findings

  • Elite quality and moat-like returns ROIC 113.9% vs WACC 13.03%; operating margin 60.4%; net margin 55.6%; ROE 76.3%
  • Hypergrowth is decelerating from extreme levels but is still very strong Revenue growth 125.9% -> 114.2% -> 65.5%; latest quarter yoy +105.85%; revenue $215.9B
  • Gross margin is slipping from its peak Gross margin 75.0% -> 71.1%; operating margin 62.4% -> 60.4% (semiconductor playbook: gross-margin trend, cycle position)
  • Excellent cash conversion, low dilution and a fortress balance sheet FCF $96.7B, conversion 81%; SBC 3.0% of revenue; diluted shares 24,940m -> 24,514m; net debt/EBITDA -0.36x; interest coverage 547x; current ratio 3.91
  • Multiples look cheap on earnings but not on FCF Trailing P/E 19.2, forward P/E 9.2, PEG 0.19, EV/EBITDA 25.8, FCF yield only 2.64%
  • The DCF is below price and the reverse DCF is demanding Scenarios bear $53.77 / base $92.17 / bull $126.65; weighted $91.19 (-39.8% vs price); implied start growth 40.3% vs base 25% (reverse DCF)

Risks

  • Customer capex cycle reversal (hyperscaler AI spending) hitting a business with extreme cyclicality and customer concentration
  • Continued gross-margin compression and growth deceleration from a very high base
  • Peak-earnings risk: a low P/E on peak earnings is a classic value trap in semis
  • Falling-knife momentum (Stage 4) with a 10-year yield at 5.06%, which pressures long-duration valuations
  • Data inconsistencies (trailing vs forward P/E, a passed earnings date with no result) lower my confidence in the multiples
⌕Accounting quality & events neutral · 55

NVDA's quantitative screens give mixed signals. The Beneish M-Score of -1.27 is above the -1.78 threshold, but it is driven mostly by very fast growth (SGI 1.655), not by receivables (DSRI ~1.0). Distress risk is essentially nil, while Piotroski is middling at 4/9 and inventory is growing faster than revenue. There are no auditor, restatement or offering flags; the main events are the post-earnings reaction (earnings were reported 2026-11-17) and recent analyst downgrades.

Key findings

  • Beneish M-Score is above the investigate threshold, but the drivers look like growth rather than manipulation M = -1.27 vs -1.78 (also above -2.22). SGI 1.655 and AQI 1.232 push it up; DSRI 1.008 (receivables are in line with sales), SGAI 0.793 and LVGI 0.807 are benign. Model is known to flag fast growers
  • Accruals ratio is high, a flag to be explained Accruals ratio (CF) 59.4% vs the >20% warning band; TATA 0.084. However, FCF conversion is 81% (FCF 96,676M on revenue 215,938M with ~55.6% net margin), so profit is largely cash-backed. The high ratio may reflect a large investing outflow or balance sheet build (unknown composition)
  • Inventory growing faster than revenue Inventory +112.33% vs revenue +65.47%. May be supply pre-building for new products, but could mean demand slowdown or write-down risk. Check inventory purchase commitments and reserves
  • Piotroski F-Score is middling 4/9. Points earned: ROA>0, CFO>0, leverage fell, no new shares. Failed: ROA improved, CFO/TA>ROA, current ratio rose, gross margin rose (75.0% to 71.1%), asset turnover rose. Weak points are mostly margin/efficiency deterioration from extreme levels, not distress
  • Distress risk negligible Altman Z 49.2 (safe), Z'' 13.22 (safe); cash 62,556M vs debt 11,040M; net debt -51,516M; interest coverage 547x; current ratio 3.91. NVDA is not a bank/insurer so scores apply (though Z is driven by market cap)
  • Earnings quality positives: low SBC and no dilution SBC 3.0% of revenue (down from 10.0% in FY2023); diluted shares 24,514M vs 24,804M (falling); goodwill 10.1% of assets (moderate)

Risks

  • Beneish above threshold plus 59.4% accruals ratio could draw scrutiny if growth slows and receivables or inventory build
  • Inventory growth outpacing revenue raises write-down risk if demand weakens
  • Gross margin compression from 75.0% to 71.1% and failed Piotroski margin/turnover tests
  • Post-earnings volatility: the 2026-11-17 report is out and the market reaction is not in the data; historical average absolute move is 4.22%, and the worst was -8.48%
  • Insider selling cluster (16 Form 4s, 4 Form 144s) with unknown direction
◍Macro, policy & credit bearish · 68

The macro backdrop is a stressed, risk-off regime for a high-beta semiconductor stock. SPY is 4.22% below its 50-day, VIX is in backwardation at 25.48, and 10y yields are around 5.1% with CPI at 4.08% yoy. NVDA lags both SPY (-25.75 pts over 3m) and its sector XLK (-18.76 pts), and with a beta of 1.78 to 2.25 it amplifies market downside. Probabilities favor a headwind until volatility normalizes and the 10y yield stops rising.

Key findings

  • The market is in an uptrend under pressure with heavy institutional selling SPY is -4.22% vs its 50-day and +0.01% vs its 200-day, with 8 distribution days in 25 sessions (5+ signals selling). QQQ is -7.98% vs its 50-day and -3.61% vs its 200-day, and IWM is -3.11% vs its 50-day. Breadth is weak, and tech is the worst hit.
  • The volatility term structure signals stress VIX is 25.48 (+47.2% in 1m) and above VIX3M at 25.0, which is backwardation. The implied SPX daily move is 1.61%. The risk appetite score is 0 out of 3.
  • Credit is risk-off but not yet crisis The HYG/LQD ratio is -0.02% over 1m (junk underperforming). The HY spread is 3.43 pp, up 0.14 pp in 1m. This is a mild widening, not a blowout. A further rise would be a warning for equities.
  • High rates and sticky inflation compress growth multiples The 10y yield is 5.06% (FRED 5.12%), 2y is 4.83%, and CPI is 4.08% yoy. Fed funds is 3.88%, so policy sits well below inflation and the market is unlikely to expect easy cuts. NVDA is a long-duration growth asset, and P = D/(r-g) shows high sensitivity to r.
  • The curve is positively sloped, so there is no inversion signal, but the cycle looks late 10y-3m is +0.77 pp (FRED), or +0.92 pp from the market data. Unemployment is 4.1% (-0.3 pp in 12m). Inflation is high and long yields are rising: 10y is +10.06% vs its 200-day. This fits a late-cycle pattern that favors energy, materials and health care over tech. Oil is -20% in 1m and copper -14.1%, which hints at slowing demand.
  • The sector and the stock are both lagging XLK is -12.25% in 1m and -6.99 pts vs SPY over 3m. NVDA is -25.75 pts vs SPY over 3m, -30.77 pts over 6m, with Mansfield RS -24.28 and the RS line not at a 52-week high.

Risks

  • The 10y yield breaking higher and further compressing growth multiples
  • VIX backwardation deepening and HY spreads widening beyond 3.43 pp
  • Sticky CPI near 4% keeping the Fed from supporting markets
  • SPY losing its 200-day (currently +0.01%, a razor-thin margin), which would shift the regime to a downtrend
  • Export-control, tariff or Taiwan shocks hitting a stock with beta above 1.7
⟋Technical analysis bearish · 85

NVDA is in a clear, high-momentum downtrend: Weinstein Stage 4, price 25-28% below all key MAs, and only 2 of 8 Trend Template checks pass. Price sits just 2.2% above its 52-week low of 148.8, with RSI2 at 2.6 and RSI14 at 21.4, so a short-term oversold bounce is plausible. There is no constructive long base, so the chart is a trend-following bearish one and any long would be a counter-trend mean-reversion trade at best.

Key findings

  • Weekly stage is 4 (declining); long-term trend down Stage 4, 30-week MA slope -1.07%, close 24.9% below 40w MA
  • Trend Template fails 2/8 passed; price 152.1 below SMA50 210.33, SMA150 210.5, SMA200 203.46; only 2.2% above 52w low (needs 30%); 37.5% below 52w high
  • Momentum is strongly bearish and stretched ADX 47 with -DI 44.6 vs +DI 8.7; MACD -16.85 below signal -13.09; RSI14 21.4 (below the 40-80 uptrend range); RSI2 2.6; TD setup -14
  • Volatility expanding, price at lower band ATR14 9.65 (6.34%); Bollinger %B 0.09; bandwidth at 100th percentile; choppiness 37.9 (trending)
  • Volume shows distribution Up/down volume ratio 0.47; CMF20 -0.08; OBV falling; 9 distribution vs 2 accumulation days in 25; 10d volume 2.35x the 50d average
  • Relative strength is very weak vs SPY 3m -25.75 pts, 6m -30.77 pts; vs sector 3m -18.76 pts; Mansfield RS -24.28; RS line not at 52w high

Risks

  • Violent oversold bounce (RSI2 2.6, price 2.2% above the 52w low) could squeeze shorts toward 169 (EMA10/Fib 0.786)
  • Last bar gapped up 2.4% but closed near the low (close location 0.14), which is weak; still, a sharp reversal is possible
  • High volatility (ATR 6.3%) makes stops wide against a $50 risk budget on a $10k account
  • Capitulation volume could mark a selling climax or Wyckoff-style spring if 148.8 is undercut and reclaimed
⇄Positioning & sentiment bearish · 60

Positioning confirms a weak price trend rather than offering a contrarian setup. Price is -29.7% over 1 month, in Stage 4, with distribution days at 9 vs 2 accumulation days, and analysts are net downgrading. Short interest is tiny, so a squeeze is not a source of upside. Options show heavy speculative call buying and elevated near-term IV, which signals fear and event risk, not capitulation.

Key findings

  • Short interest is negligible, so squeeze fuel is absent and shorts are not driving the decline 1.21% of float, 2.71 days to cover, -10.22% vs prior month, squeeze_risk low
  • Insiders are only selling, with no buying to signal conviction at lower prices 0 open-market buys, 0 distinct buyers, 9 sales worth $1,370.53M in 180d. Sales are a weak signal (taxes, plans)
  • Institutional ownership is high and mixed, so crowding risk exists if exits accelerate Institutions 71.42%. FMR -9.09%, Norges -2.34%, vs State Street +1.51%, JPM +2.84%. 4 of top 10 net adding. 13F data lags ~45 days, so it may be stale
  • Volume pattern shows distribution Distribution days 9 vs accumulation 2 (25d), CMF20 -0.08, OBV falling, up/down volume ratio 0.47, last volume 195.7M vs 50d avg 157.7M
  • Options are near fair value but event-heavy, with a call-skewed speculative bid and some hedging demand ATM IV 59.8% (5 DTE) vs 53.6% (30 DTE) vs 50.7% (58 DTE), inverted. IV/HV20 1.04 (fair). 5-day expected move ±6.13% ($142.77-$161.42). Put skew +7.4 pts. P/C volume 0.6 (5 DTE) and 0.34 (30 DTE)
  • Unusual call activity is concentrated in out-of-the-money strikes, but volume vs OI alone does not reveal direction or who is on the other side Dec $205 calls: 45,969 volume vs 16,959 OI. Nov 23 $160 calls: 14,661 vs 4,250 OI. Spot is $152.1, so these are bets on a rebound. Could be a spread, a hedge or a dealer position

Risks

  • Leadership transition uncertainty could drive further downside or sharp gaps
  • Crowded institutional ownership (71.42%) means large holders trimming could add pressure
  • Elevated market stress (VIX 25.48, backwardation) can amplify moves
  • Price is only 2.21% above the 52w low of $148.8. A break could trigger stops
  • A sharp oversold bounce is possible, with heavy call buying and dealer gamma adding fuel to rallies in the short term
⚡Trading plans

NVDA is in a Stage 4 downtrend (2/8 Trend Template checks, price 152.1 vs SMA50 210.33). Intraday it trades below VWAP 153.06 with RVOL 3.13, so it is in play, but the day is mixed (4 VWAP crosses) and SPY is under pressure with VIX 25.48 in backwardation. The cleanest plans are short-side rules: a VWAP rejection or a break of the 148.8 low. A swing short is possible only as a conditional breakdown, and there is no valid long swing. The Donchian system is flat-to-short.

◇Options

NVDA is in a Stage 4 downtrend with a bearish technical, flow and macro read (confidence 85, 60 and 68). Fundamentals are neutral, and RSI2 of 2.6 with price 2.2% above the 52-week low means a violent bounce is a real risk. The only candidate that fits the $100 options-risk cap and the bearish view is the Dec 18 152/150 bear put debit spread. Long ITM puts cost $1,908-$2,352 per contract and are far too big for a $10k account. Credit structures either fight the trend or pay too little.

⛨Risk management

NVDA is a very high-risk tape: ATR14 is 6.34% of price, beta is 2.25, VIX is 25.48 in backwardation, and the stock sits 2.2% above its 52-week low after earnings on 11/17 and CEO-succession headlines. Day_2 has a hard violation (R:R 1.0 vs the 1.5 minimum) and is rejected. Day_1 and day_3 pass the checks but only with a reduced size, and the options spread is acceptable at 1 contract. Capital preservation comes first: the $10k account has a $50 R and a $200 daily loss cap, and RSI2 of 2.6 makes a violent bounce a real danger to shorts.

Risks

  • Oversold squeeze: RSI2 2.6 with price 2.2% above the 52-week low. A sharp bounce hits shorts, especially with heavy call buying (Dec $205 calls: 45,969 volume vs 16,959 OI).
  • Volatility: ATR14 6.34%, annual vol 38.8%, beta 2.25, VaR95 1-day 4.03%. Tight stops of 1.1-1.4 points are inside normal intraday noise.
  • Event/gap risk: post-earnings drift after 11/17, CEO-succession headlines, an unknown 8-K 5.02 officer change, and 10 gaps over 3% in 1y. Stops can gap through, so the actual loss can exceed $50.
  • Macro regime: SPY is 4.22% below its 50-day and only 0.01% above its 200-day, with 8 distribution days and VIX in backwardation. A SPY close below the 200-day would raise the risk of fast moves in both directions.
  • Position cap: the 25% cap, not the risk budget, sets the share count. That means a concentrated, large notional position in one high-beta name.

Key data

Price$152.10
Market cap$3,659.96B
1M / 1Y return-29.74% / -18.30%
vs 52-week high-37.50%
Trend stageStage 4 - declining (price below falling 30-week MA)
Trend Template2/8
RSI (14) / ADX21.4 / 47.0
ATR % of price6.34%
Support148.80
Resistance214.06, 221.09
P/E (trailing / forward)19.2 / 9.2
EV / EBITDA25.8
FCF yield2.64%
ROIC113.9%
Net debt / EBITDA-0.36
Street target (mean)$253.67
Next earnings2026-11-17
Avg earnings move4.22%
ATM implied vol59.8%
Options expected move6.13%
IV vs realizedfair
Short interest (float)1.21%
Market regimeuptrend under pressure (SPY below 50-day, above 200-day)
VIX / 10-yr yield25.48 / 5.06%

Figures are calculated from public market data at the time of the report and may be delayed or inaccurate.

Report details

Published
Prices and data as of
Data sourcesYahoo Finance · SEC EDGAR · FRED

Research methodology → · Disclaimer